Co-Diagnostics, Inc. Gain (Loss) on Disposition of Assets
Co-Diagnostics, Inc. (CODX) reported Gain (Loss) on Disposition of Assets of -$82.42 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-13
- Co-Diagnostics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was -$77.42K, a 6157.67% decline year-over-year.
- Co-Diagnostics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $4.00K, a 13.86% increase year-over-year.
- Co-Diagnostics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-06-30 was -$9.00K, a 357.26% decline year-over-year.
- Co-Diagnostics, Inc. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $1.28K.
- Co-Diagnostics, Inc. gain (loss) on disposition of assets for fiscal 2025 was -$82.42K, a 1094.10% decline from fiscal 2024.
- Co-Diagnostics, Inc. gain (loss) on disposition of assets for fiscal 2024 was $8.29K.
- Co-Diagnostics, Inc. gain (loss) on disposition of assets for fiscal 2023 was -$2.58K.
- Co-Diagnostics, Inc. gain (loss) on disposition of assets for fiscal 2022 was -$138.12K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$77.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$73.42K derived: sum of 2 quarters · filed 2026-03-31 | -$82.42K derived: sum of 3 quarters · filed 2026-08-13 | -$82.42K 10-K · filed 2026-03-31 |
| 2025-09-30 | $4.00K 10-Q · filed 2025-11-13 | -$5.00K derived: sum of 2 quarters · filed 2026-08-13 | -$5.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$9.00K 10-Q · filed 2026-08-13 | -$9.00K 10-Q · filed 2026-08-13 | ||
| 2024-12-31 | $1.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.79K derived: sum of 2 quarters · filed 2026-03-31 | $8.29K derived: sum of 3 quarters · filed 2026-03-31 | $8.29K 10-K · filed 2026-03-31 |
| 2024-09-30 | $3.51K 10-Q · filed 2025-11-13 | $7.01K derived: sum of 2 quarters · filed 2025-11-13 | $7.01K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $3.50K 10-Q · filed 2025-08-14 | $3.50K 10-Q · filed 2025-08-14 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$2.58K derived: sum of 2 quarters · filed 2025-03-27 | -$2.58K 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$2.58K 10-Q · filed 2024-11-07 | -$2.58K 10-Q · filed 2024-11-07 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $4.04K derived: sum of 2 quarters · filed 2024-03-14 | -$44.70K derived: sum of 3 quarters · filed 2024-03-14 | -$138.12K 10-K · filed 2024-03-14 |
| 2022-09-30 | $4.04K 10-Q · filed 2023-11-09 | -$44.70K derived: sum of 2 quarters · filed 2023-11-09 | -$138.12K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$48.74K 10-Q · filed 2023-08-10 | -$142.16K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$93.42K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$44.35K 10-K · filed 2023-03-16 | |||
| 2020-12-31 | -$175.00 10-K · filed 2022-03-24 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $850.00 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $850.00 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $850.00 10-Q/A · filed 2020-11-03 | ||
| 2019-03-31 | $850.00 10-Q · filed 2020-05-14 | |||
| 2017-09-30 | -$1.28K 10-Q · filed 2018-11-14 | -$1.28K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |